Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emcure Pharmaceuticals Ltd.

www.emcure.co.in

Latest From Emcure Pharmaceuticals Ltd.

Eisai-Mylan Tango for Second Halaven Brand In India But Eyes On Pricing, Generics

Eisai has struck a deal with Mylan for a second brand of Halaven in India, joining a growing list of foreign firms deploying this approach to expand access to novel therapies in the country amid emerging competition.

India Commercial

US Price-Fixing Litigation Presses On With 'Overarching Conspiracy' Claims Intact

Judge allows plaintiffs to argue attendance at trade association meetings and job-hopping show scheme to fix drug prices; confidentiality of attorney communication is in dispute.

Generic Drugs Pricing Strategies

Generic Price Fixing Litigation Presses On With 'Overarching Conspiracy' Claims Intact

Judge allows plaintiffs to argue attendance at trade association meetings and job-hopping show scheme to fix drug prices; confidentiality of attorney communication is in dispute.

Generic Drugs Pricing Strategies

Two India Firms In Fresh FDA Trouble: Emcure Hit By Warning Letter, Dr Reddy’s Gets 483

The US regulator has slammed India’s Emcure Pharmaceuticals in a warning letter, accusing the company of slipshod investigation of tests showing microbial contamination and poor supervision, and has also sent a Form 483 containing eight observations to Dr Reddy’s.

Manufacturing Compliance
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Emcure Pharmaceuticals Ltd.
  • Senior Management
  • Satish R Mehta, Managing Dir. & CEO
  • Contact Info
  • Emcure Pharmaceuticals Ltd.
    Phone: (91) 20 30610000
    Emcure House, T 184
    Bhosari
    Pune, 411026
    India
UsernamePublicRestriction

Register